Unusual Machines should rerate well because its thesis was always about being US made and US owned, with Trump ownership simply gravy. Per @BussinBiotech, recent reporting makes it the big winner, and its stock, which had lagged Kopin, LightPath and Ondas, looks about to change course. x.comÂ

